The Role of 3-Guanidinopropionic Acid in Metabolic Health Research
In the ever-evolving landscape of biochemical and pharmaceutical research, understanding the intricate pathways of metabolic health is paramount. One compound that has garnered significant attention for its potential in this area is 3-Guanidinopropionic Acid, identified by CAS number 353-09-3. As a leading manufacturer and supplier of high-quality fine chemicals in China, we are committed to providing researchers and formulators with the essential building blocks they need. This article delves into the properties and research applications of 3-Guanidinopropionic Acid, highlighting its significance for those looking to buy this critical intermediate.
3-Guanidinopropionic Acid is a fascinating molecule, classified as a guanidine derivative and a creatine analogue. Its chemical structure allows it to interact with key metabolic pathways, leading to investigations into its therapeutic potential. Research suggests that it may play a role in improving insulin sensitivity, a crucial factor in managing conditions like type 2 diabetes and metabolic syndrome. For procurement managers and R&D scientists seeking to explore these avenues, understanding the availability and quality of suppliers is key. Sourcing from a reputable manufacturer in China ensures access to high-purity material, often with a purity of 99%, which is essential for reliable experimental results and product development.
The therapeutic applications being explored for 3-Guanidinopropionic Acid are diverse. Studies indicate its ability to ameliorate hyperglycemia and reduce adipose tissue weight, suggesting a potential role in treating and preventing metabolic disorders. This makes it a compound of interest for pharmaceutical companies developing new drugs. When considering the purchase of such specialized intermediates, engaging with a reliable supplier who can provide detailed technical specifications and consistent product quality is vital. The price of 3-Guanidinopropionic Acid can vary, but for bulk purchases, working directly with a manufacturer offers significant cost advantages and ensures a stable supply chain.
The synthesis of 3-Guanidinopropionic Acid is a testament to advanced chemical manufacturing processes. Typically produced through a two-step alkylation reaction, the resulting product is a white crystalline powder. Its common synonyms include 3-Guanidinopropanoate and beta-Guanidinopropionic acid. For those in the market to buy this intermediate, looking for manufacturers who can guarantee consistent quality and competitive pricing is a strategic move. The availability of this compound from China-based suppliers, such as our company, offers global access to this important biochemical and pharmaceutical intermediate. We understand the critical needs of researchers and industrial clients and strive to be a dependable source for compounds like 3-Guanidinopropionic Acid.
In conclusion, 3-Guanidinopropionic Acid (CAS 353-09-3) is more than just a chemical compound; it's a vital tool for advancing research in metabolic health and drug development. Its properties as a creatine analogue and its potential therapeutic benefits make it a sought-after intermediate. For procurement professionals and scientists, partnering with a trusted manufacturer and supplier in China provides access to high-quality 3-Guanidinopropionic Acid at competitive prices, facilitating innovation and production efficiency.
Perspectives & Insights
Silicon Analyst 88
“For procurement professionals and scientists, partnering with a trusted manufacturer and supplier in China provides access to high-quality 3-Guanidinopropionic Acid at competitive prices, facilitating innovation and production efficiency.”
Quantum Seeker Pro
“In the ever-evolving landscape of biochemical and pharmaceutical research, understanding the intricate pathways of metabolic health is paramount.”
Bio Reader 7
“One compound that has garnered significant attention for its potential in this area is 3-Guanidinopropionic Acid, identified by CAS number 353-09-3.”